Daniel J DeAngelo

64PUBLICATIONS
366CO-AUTHORS
Molecular targetsCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Nov 06, 2026
A living enzymatic adenosine switch couples metabolic rescue to IL-12-driven antitumor immunity.

|Oct 15, 2026
Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.

|Oct 09, 2026
Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin.

|Oct 05, 2026
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

|Sep 25, 2026
Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

Pageof 11

Frequent Collaborators

22 joint publications

Marlise R Luskin

16 joint publications

Jacqueline S Garcia

14 joint publications

Shai Shimony

9 joint publications

Eric S Winer